Building clinical trials capacity for tuberculosis drugs in high-burden countries.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17988170.
- Also identified by PMC identifier 2062480.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The long duration of TB therapy, the high prevalence of HIV coinfection, and the growing prevalence of drug-resistant TB underscore the urgent need for more effective treatments.
Medical subject headings
- Antitubercular Agents
- Clinical Trials as Topic
- Tuberculosis
- Tuberculosis, Multidrug-Resistant